Murphy S, Friesner DL, Rosenman R, Waslo CS, Au J, Tanne E. Emergency department utilization among individuals with idiopathic intracranial hypertension. Int J Health Care Qual Assur. 2019;32(1):152–63. https://doi.org/10.1108/IJHCQA-04-2017-0060.

Article  PubMed  PubMed Central  Google Scholar 

Friesner D, Rosenman R, Lobb BM, et al. Idiopathic intracranial hypertension in the USA: the role of obesity in establishing prevalence and healthcare costs. Obes Rev. 2011;12:e372–80.

Article  CAS  PubMed  Google Scholar 

Onyia CU, Ogunbameru IO, Dada OA, Owagbemi OF, Ige-Orhionkpaibima FS, Olarewaju OA, Komolafe EO. Idiopathic intracranial hypertension: proposal of a stratification strategy for monitoring risk of disease progression. Clin Neurol Neurosurg. 2019;179:35–41. https://doi.org/10.1016/j.clineuro.2019.02.013. Epub 2019 Feb 15 PMID: 30818126.

Article  PubMed  Google Scholar 

Ottridge R, Mollan SP, Botfield H, Frew E, Ives NJ, Matthews T, Mitchell J, Rick C, Singhal R, Woolley R, Sinclair AJ. Randomised controlled trial of bariatric surgery versus a community weight loss programme for the sustained treatment of idiopathic intracranial hypertension: the Idiopathic Intracranial Hypertension Weight Trial (IIH:WT) protocol. BMJ Open. 2017;7(9):e017426. https://doi.org/10.1136/bmjopen-2017-017426. PMID: 28963303; PMCID: PMC5623580.

Westgate CSJ, Markey K, Mitchell JL, Yiangou A, Singhal R, Stewart P, Tomlinson JW, Lavery GG, Mollan SP, Sinclair AJ. Increased systemic and adipose 11β-HSD1 activity in idiopathic intracranial hypertension. Eur J Endocrinol. 2022;187(2):323–33. https://doi.org/10.1530/EJE-22-0108. PMID: 35584002; PMCID: PMC9346265.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mollan SP, Wakerley BR, Alimajstorovic Z, Mitchell J, Ottridge R, Yiangou A, Thaller M, Gupta A, Grech O, Lavery G, Brock K, Sinclair AJ. Intracranial pressure directly predicts headache morbidity in idiopathic intracranial hypertension. J Headache Pain. 2021;22(1):118. https://doi.org/10.1186/s10194-021-01321-8.PMID:34620087;PMCID:PMC8499560.

Article  CAS  PubMed  PubMed Central  Google Scholar 

•• Mollan SP, Davies B, Silver NC, Shaw S, Mallucci CL, Wakerley BR, Krishnan A, Chavda SV, Ramalingam S, Edwards J, Hemmings K, Williamson M, Burdon MA, Hassan-Smith G, Digre K, Liu GT, Jensen RH, Sinclair AJ. Idiopathic intracranial hypertension: consensus guidelines on management. J Neurol Neurosurg Psychiatry. 2018;89(10):1088–1100. https://doi.org/10.1136/jnnp-2017-317440. Epub 2018 Jun 14. PMID: 29903905; PMCID: PMC6166610. This article provides the most recent expert opinion and guidelines covering IIH management, including medications and doses for possible symptomatic relief.

• Rohit W, Rajesh A, Mridula R, Jabeen SA. Idiopathic intracranial hypertension - challenges and pearls. Neurol India. 2021;69(Supplement):S434–S442. https://doi.org/10.4103/0028-3886.332276. PMID:35103000. A comprehensive overview of the diagnosis and management of IIH, including the diagnostic modified Dandy criteria, as well as therapeutic guidelines.

• Toscano S, Lo Fermo S, Reggio E, Chisari CG, Patti F, Zappia M. An update on idiopathic intracranial hypertension in adults: a look at pathophysiology, diagnostic approach and management. J Neurol. 2021;268(9):3249–68. https://doi.org/10.1007/s00415-020-09943-9. A recent review article about the diagnosis and management of IIH, including demographics, symptoms, imaging, and therapeutics.

Article  PubMed  Google Scholar 

Ahmad SR, Moss HE. Update on the diagnosis and treatment of idiopathic intracranial hypertension. Semin Neurol. 2019;39(6):682–691. https://doi.org/10.1055/s-0039-1698744. Epub 2019 Dec 17. PMID: 31847039; PMCID: PMC7713505.

Bouffard MA. Fulminant idiopathic intracranial hypertension. Curr Neurol Neurosci Rep. 2020;20(4):8. https://doi.org/10.1007/s11910-020-1026-8. PMID: 32219578.

Article  PubMed  Google Scholar 

Perez FA. Imaging of nontraumatic orbital and neuro-ophthalmological emergencies. Semin Roentgenol. 2020;55(2):132–49. https://doi.org/10.1053/j.ro.2019.11.004. Epub 2019 Nov 16 PMID: 32438976.

Article  PubMed  Google Scholar 

Mollan SP, Hornby C, Mitchell J, Sinclair AJ. Evaluation and management of adult idiopathic intracranial hypertension. Pract Neurol. 2018;18(6):485–488. https://doi.org/10.1136/practneurol-2018-002009. Epub 2018 Aug 28. PMID: 30154235; PMCID: PMC6252364.

del Saz-Saucedo P, Redondo-González O, Mateu-Mateu Á, Huertas-Arroyo R, García-Ruiz R, Botia-Paniagua E. Sonographic assessment of the optic nerve sheath diameter in the diagnosis of idiopathic intracranial hypertension. J Neurol Sci. 2016;15(361):122–7.

Article  Google Scholar 

Dong J, Li Q, Wang X, Fan Y. A review of the methods of non-invasive assessment of intracranial pressure through ocular measurement. Bioengineering (Basel). 2022;9(7):304. https://doi.org/10.3390/bioengineering9070304. PMID: 35877355; PMCID: PMC9312000.

Article  PubMed  Google Scholar 

Kishk NA, Ebraheim AM, Ashour AS, Badr NM, Eshra MA. Optic nerve sonographic examination to predict raised intracranial pressure in idiopathic intracranial hypertension: The cut-off points. Neuroradiol J. 2018;31(5):490–495. https://doi.org/10.1177/1971400918789385. Epub 2018 Jul 19. PMID: 30024291; PMCID: PMC6136137.

De Bernardo M, Vitiello L, De Pascale I, Capasso L, Cornetta P, Rosa N. Optic nerve ultrasound evaluation in idiopathic intracranial hypertension. Front Med (Lausanne). 2022;9:845554. https://doi.org/10.3389/fmed.2022.845554. PMID: 35299843; PMCID: PMC8921495.

Rosa N, De Bernardo M. Ultrasound assessment of optic nerve sheath diameter in healthy volunteers. J Crit Care. 2017;40:279. https://doi.org/10.1016/j.jcrc.2017.03.018. Epub 2017 Mar 27 PMID: 28372887.

Article  PubMed  Google Scholar 

Sankey EW, Elder BD, Liu A, Carson KA, Goodwin CR, Jusué-Torres I, Rigamonti D. Predictors of admission and shunt revision during emergency department visits for shunt-treated adult patients with idiopathic intracranial hypertension. J Neurosurg. 2017;127(2):233–9. https://doi.org/10.3171/2016.5.JNS151303. Epub 2016 Sep 23 PMID: 27662535.

Article  PubMed  Google Scholar 

Cho T, Kreatsoulas D, Fritz J, McGregor JM, Hardesty DA. An institutional review of hospital resource utilization and patient radiation exposure in shunted idiopathic intracranial hypertension. Neurosurg Rev. 2021;44(6):3359–73. https://doi.org/10.1007/s10143-021-01502-8. Epub 2021 Feb 21 PMID: 33611722.

Article  PubMed  Google Scholar 

Liu A, Elder BD, Sankey EW, Goodwin CR, Jusué-Torres I, Rigamonti D. Are shunt series and shunt patency studies useful in patients with shunted idiopathic intracranial hypertension in the emergency department? Clin Neurol Neurosurg. 2015;138:89–93. https://doi.org/10.1016/j.clineuro.2015.08.008. Epub 2015 Aug 13 PMID: 26302017.

Article  CAS  PubMed  Google Scholar 

Jones JS, Nevai J, Freeman MP, McNinch DE. Emergency department presentation of idiopathic intracranial hypertension. Am J Emerg Med. 1999;17(6):517–21. https://doi.org/10.1016/s0735-6757(99)90188-2. PMID: 10530526.

Article  CAS  PubMed  Google Scholar 

•• Piper RJ, Kalyvas AV, Young AMH, Hughes MA, Jamjoom AAB, Fouyas IP. Interventions for idiopathic intracranial hypertension. Cochrane Database of Systematic Reviews 2015, Issue 8. Art. No.: CD003434. https://doi.org/10.1002/14651858.CD003434.pub3. Accessed 04 November 2022. While from 2015, this is the only systematic review of medication therapy for treatment of IIH.

Scotton WJ, Botfield HF, Westgate CS, Mitchell JL, Yiangou A, Uldall MS, et al. Topiramate is more effective than acetazolamide at lowering intracranial pressure. Cephalalgia. 2019;39:209–18.

Article  PubMed  Google Scholar 

Mollan SP, Grech O, Sinclair AJ. Headache attributed to idiopathic intracranial hypertension and persistent post-idiopathic intracranial hypertension headache: a narrative review. Headache. 2021;61(6):808–16. https://doi.org/10.1111/head.14125. Epub 2021 Jun 9 PMID: 34106464.

Article  PubMed  Google Scholar 

Mollan SP, Mitchell JL, Ottridge RS, et al. Effectiveness of bariatric surgery vs community weight management intervention for the treatment of idiopathic intracranial hypertension: a randomized clinical trial. JAMA Neurol. 2021;78(6):678–86. https://doi.org/10.1001/jamaneurol.2021.0659.

Article  PubMed  PubMed Central  Google Scholar 

• Hornby C, Mollan SP, Botfield H, OʼReilly MW, Sinclair AJ. Metabolic concepts in idiopathic intracranial hypertension and their potential for therapeutic intervention. J Neuroophthalmol. 2018;38(4):522–530. https://doi.org/10.1097/WNO.0000000000000684. PMID: 29985799; PMCID: PMC6215484. Provides an overview of current epidemiology of IIH and associations between obesity and IIH and proposes a new metabolic/endocrine mechanism for further investigation.

Sinclair AJ, Onyimba CU, Khosla P, Vijapurapu N, Tomlinson JW, Burdon MA, et al. Corticosteroids, 11beta-hydroxysteroid dehydrogenase isozymes and the rabbit choroid plexus. J Neuroendocrinol. 2007;19:614–20.

Article  CAS  PubMed  Google Scholar 

Markey K, Mitchell J, Botfield H, Ottridge RS, Matthews T, Krishnan A, Woolley R, Westgate C, Yiangou A, Alimajstorovic Z, Shah P, Rick C, Ives N, Taylor AE, Gilligan LC, Jenkinson C, Arlt W, Scotton W, Fairclough RJ, Singhal R, Stewart PM, Tomlinson JW, Lavery GG, Mollan SP, Sinclair AJ. 11β-Hydroxysteroid dehydrogenase type 1 inhibition in idiopathic intracranial hypertension: a double-blind randomized controlled trial. Brain Commun. 2020;2(1):fcz050. https://doi.org/10.1093/braincomms/fcz050. Erratum in: Brain Commun. 2020;2(2):fcaa108. PMID: 32954315; PMCID: PMC7425517.

Hardy RS, Botfield H, Markey K, Mitchell JL, Alimajstorovic Z, Westgate CSJ, Sagmeister M, Fairclough RJ, Ottridge RS, Yiangou A, Storbeck KH, Taylor AE, Gilligan LC, Arlt W, Stewart PM, Tomlinson JW, Mollan SP, Lavery GG, Sinclair AJ. 11βHSD1 inhibition with AZD4017 improves lipid profiles and lean muscle mass in idiopathic intracranial hypertension. J Clin Endocrinol Metab. 2021;106(1):174–87. https://doi.org/10.1210/clinem/dgaa766. PMID: 33098644; PMCID: PMC7765633.

Article  PubMed  Google Scholar 

Mitchell JL, Mollan SP, Vijay V, Sinclair AJ. Novel advances in monitoring and therapeutic approaches in idiopathic intracranial hypertension. Curr Opin Neurol. 2019;32(3):422–31. https://doi.org/10.1097/WCO.0000000000000690. PMID: 30865008; PMCID: PMC6522204.

Article  PubMed  PubMed Central  Google Scholar 

Botfield HF, Uldall MS, Westgate CSJ, et al. A glucagon-like peptide-1 receptor agonist reduces intracranial pressure in a rat model of hydrocephalus. Sci Transl Med Am. 2017 Aug 23;9(404):eaan0972. https://doi.org/10.1126/scitranslmed.aan0972.

Mitchell JL, Lyons HS, Walker JK, Yiangou A, Grech O, Alimajstorovic Z, Greig NH, Li Y, Tsermoulas G, Brock K, Mollan SP, Sinclair AJ. The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial. Brain. 2023;146(5):1821–30. https://doi.org/10.1093/brain/awad003. PMID: 36907221; PMCID: PMC10151178.

Article  PubMed  PubMed Central  Google Scholar 

Kabanovski A, Kisilevsky E, Yang Y, Margolin E. Dural venous sinus stenting in the treatment of idiopathic intracranial hypertension: a systematic review and critique of literature. Surv Ophthalmol. 2022 Jan-Feb;67(1):271–287. https://doi.org/10.1016/j.survophthal.2021.05.002. Epub 2021 May 15. PMID: 34004224.

Thurtell MJ, Kawasaki A. Update in the management of idiopathic intracranial hypertension. Neurol Clin. 2021;39(1):147–61. https://doi.org/10.1016/j.ncl.2020.09.008. Epub 2020 Nov 7 PMID: 33223080.

Article  PubMed  Google Scholar 

Salih M, Enriquez-Marulanda A, Khorasanizadeh M, Moore J, Prabhu VC, Ogilvy CS. Cerebrospinal fluid shunting for idiopathic intracranial hypertension: a systematic review, meta-analysis, and implications for a modern management protocol. Neurosurgery. 2022;91(4):529–40. https://doi.org/10.1227/neu.0000000000002086. Epub 2022 Aug 4 PMID: 35916578.

Article  PubMed  Google Scholar 

Aylward SC, Way AL. (2018). Pediatric intracranial hypertension: a current literature review. Curr Pain Headache Reps. 22(2). https://doi.org/10.1007/s11916-018-0665-9.

Irazuzta JE, Brown ME, Akhtar J. Bedside optic nerve sheath diameter assessment in the identification of increased intracranial pressure in suspected idiopathic intracranial hypertension. Pediatr Neurol. 2016;54:35–8. https://doi.org/10.1016/j.pediatrneurol.2015.08.009.

Article  PubMed  Google Scholar 

Carter SB, Pistilli M, Livingston KG, Gold DR, Volpe NJ, Shindler KS, et al. The role of orbital ultrasonography in distinguishing papilledema from pseudopapilledema. Eye (Lond). 2014;28(12):1425–30. https://doi.org/10.1038/eye.2014.210.

Article  CAS  PubMed  Google Scholar 

Hartmann AJ, Soares BP, Bruce BB, Saindane AM, Newman NJ, Biousse V, et al. Imaging features of idiopathic intracranial hyper- tension in children. J Child Neurol. 2017;32(1):120–6. https://doi.org/10.1177/0883073816671855.

Vitaliti G, Pavone P, Matin N, Tabatabaie O, Cocuzza S, Vecchio M, Maiolino L, Di Mauro P, Conti A, Lubrano R, Serra A, Falsaperla R. Therapeutic approaches to pediatric pseudotumor cerebri: new insights from literature data. Int J Immunopathol Pharmacol. 2017;30(1):94–97. https://doi.org/10.1177/0394632016681578. Epub 2017 Jan 24. PMID: 27903844; PMCID: PMC5806786.

Scott C, Kaliaperumal C. Idiopathic intracranial hypertension and pregnancy: a comprehensive review of management. Clin Neurol Neurosurg. 2022 Jun;217:107240. https://doi.org/10.1016/j.clineuro.2022.107240. Epub 2022 Apr 13. PMID: 35461091.

Negro A, Delaruelle Z, Ivanova TA, Khan S, Ornello R, Raffaelli B, Terrin A, Reuter U, Mitsikostas DD; European Headache Federation School of Advanced Studies (EHF-SAS). Headache and pregnancy: a systematic review. J Headache Pain. 2017;18(1):106. https://doi.org/10.1186/s10194-017-0816-0. PMID: 29052046; PMCID: PMC5648730.